Your browser doesn't support javascript.
loading
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma.
Kim, Do Young; Nam, Jehyun; Chung, Joo-Seop; Kim, Sang-Woo; Shin, Ho-Jin.
Afiliación
  • Kim DY; Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
  • Nam J; Department of Biological Sciences, Pusan National University, Busan, Korea.
  • Chung JS; Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
  • Kim SW; Department of Biological Sciences, Pusan National University, Busan, Korea.
  • Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
Cancer Res Treat ; 54(1): 301-313, 2022 Jan.
Article en En | MEDLINE | ID: mdl-33940789

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Benzamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Inhibidores de Fosfodiesterasa 4 / Aminopiridinas Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Año: 2022 Tipo del documento: Article Pais de publicación:

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Benzamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Inhibidores de Fosfodiesterasa 4 / Aminopiridinas Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Año: 2022 Tipo del documento: Article Pais de publicación: